Nurse-Led Motivational Interviewing for Blood Pressure Control
The Effect of Nurse-Led Individual and Family-Involved Motivational Interviewing on Blood Pressure Control in Patients With Hypertension: A Three-Arm Randomized Controlled Trial
1 other identifier
interventional
180
1 country
1
Brief Summary
Hypertension is one of the most important risk factors for cardiovascular morbidity and mortality. Effective hypertension management requires medication adherence, lifestyle modification, regular blood pressure monitoring, and self-management behaviors. Motivational interviewing is a counseling approach that may support behavior change and improve hypertension management. This study aims to evaluate the effects of nurse-led individual motivational interviewing and family-involved motivational interviewing on blood pressure control in patients with hypertension. The study will be conducted as a single-center, three-arm, parallel-group, randomized controlled trial. A total of 180 patients with hypertension will be randomly assigned to one of three groups: usual care, individual motivational interviewing, or family-involved motivational interviewing. Participants in the intervention groups will receive a 6-week nurse-led motivational interviewing program. In the family-involved motivational interviewing group, a family member who supports hypertension management will also participate in the sessions. Data will be collected at baseline, 6 weeks, and 18 weeks. The primary outcome is systolic blood pressure. Secondary outcomes include diastolic blood pressure, hypertension knowledge level, treatment adherence, and hypertension self-efficacy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable hypertension
Started Aug 2026
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 30, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedFirst Posted
Study publicly available on registry
August 5, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
August 12, 2026
July 1, 2026
5 months
July 30, 2026
August 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Systolic Blood Pressure
Systolic blood pressure will be measured in mmHg using a standard blood pressure measurement procedure. Measurements will be taken after at least 5 minutes of rest using an appropriate cuff. At each assessment, at least two measurements will be taken from the same arm, and the average value will be used in the analysis. Lower systolic blood pressure values indicate better blood pressure control.
Baseline, 6 weeks, and 18 weeks
Secondary Outcomes (4)
Diastolic Blood Pressure
Baseline, 6 weeks, and 18 weeks
Hypertension Knowledge Level Assessed by the Hypertension Knowledge-Level Scale
Baseline, 6 weeks, and 18 weeks
Treatment Adherence Assessed by the Hill-Bone Hypertension Treatment Adherence Scale
Baseline, 6 weeks, and 18 weeks
Hypertension Self-Efficacy Assessed by the Hypertension Self-Efficacy Scale
Baseline, 6 weeks, and 18 weeks
Study Arms (3)
Usual Hypertension Care With Information Brochure
ACTIVE COMPARATORParticipants in this arm will continue to receive routine hypertension care. They will also receive a standard hypertension information brochure. No structured motivational interviewing intervention will be provided.
Nurse-Led Individual Motivational Interviewing
EXPERIMENTALParticipants in this arm will receive a 6-week nurse-led individual motivational interviewing program in addition to routine hypertension care. The intervention will focus on hypertension awareness, medication adherence, lifestyle modification, home blood pressure monitoring, physical activity, stress management, self-efficacy, problem solving, and maintenance of motivation.
Nurse-Led Family-Involved Motivational Interviewing
EXPERIMENTALParticipants in this arm will receive the same 6-week nurse-led motivational interviewing program in addition to routine hypertension care, with the participation of a family member who supports hypertension management. The family member may support medication adherence, salt reduction, nutrition behaviors, home blood pressure monitoring, and weekly goals.
Interventions
The intervention is a structured 6-week nurse-led individual motivational interviewing program. Sessions will focus on hypertension awareness, individual risk factors, readiness for change, hypertension knowledge, misconceptions and complications, medication adherence, treatment barriers, salt reduction, nutrition behaviors, home blood pressure monitoring, physical activity, weight control, stress management, self-efficacy, problem solving, motivation maintenance, and individualized goal evaluation.
The intervention is a structured 6-week nurse-led motivational interviewing program delivered with the participation of a family member who supports the patient's hypertension management. The intervention content is the same as the individual motivational interviewing program. The family member will be included to support medication adherence, salt reduction, nutrition behaviors, home blood pressure monitoring, and achievement of weekly goals.
Participants will continue to receive routine hypertension care and will be given a standard hypertension information brochure. No structured motivational interviewing session will be provided.
Eligibility Criteria
You may qualify if:
- Aged 18 years or older
- Diagnosed with hypertension for at least 6 months
- Using antihypertensive medication
- Able to read and understand Turkish
- Conscious and able to communicate
- Providing written informed consent
- Having at least one family member who can support hypertension management and participate in sessions when needed
You may not qualify if:
- Advanced cognitive impairment
- Active psychiatric crisis
- History of a serious cardiovascular event within the last 3 months
- Terminal illness
- Serious physical condition that may prevent regular participation in intervention sessions
- Concurrent participation in another structured education program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Simav Doc. Dr. Ismail Karakuyu State Hospital
Simav, Turkey (Türkiye)
Related Publications (3)
Mehta SJ, Volpp KG, Troxel AB, Teel J, Reitz CR, Purcell A, Shen H, McNelis K, Snider CK, Asch DA. Remote Blood Pressure Monitoring With Social Support for Patients With Hypertension: A Randomized Clinical Trial. JAMA Netw Open. 2024 Jun 3;7(6):e2413515. doi: 10.1001/jamanetworkopen.2024.13515.
PMID: 38829618BACKGROUNDKhadoura KJ, Shakibazadeh E, Mansournia MA, Aljeesh Y, Fotouhi A. Effectiveness of motivational interviewing on medication adherence among Palestinian hypertensive patients: a clustered randomized controlled trial. Eur J Cardiovasc Nurs. 2021 Jun 29;20(5):411-420. doi: 10.1093/eurjcn/zvaa015.
PMID: 34009313BACKGROUNDXu J, Gu X, Gu J, Zhao L, Li M, Hong C. Motivational interviewing intervention for the management of hypertension: a meta-analysis. Front Cardiovasc Med. 2025 Jan 20;11:1457039. doi: 10.3389/fcvm.2024.1457039. eCollection 2024.
PMID: 39902088BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Participants and intervention providers cannot be masked due to the nature of the behavioral intervention. Outcome assessment and data analysis will be conducted with group codes masked.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 30, 2026
First Posted
August 5, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
December 31, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
August 12, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared because the study includes health-related information from patients with hypertension. De-identified aggregate results may be reported in scientific publications.